4//SEC Filing
CLEVELAND BIOLABS INC 4
Accession 0001209191-14-060643
CIK 0001318641operating
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 5:47 PM ET
Size
11.3 KB
Accession
0001209191-14-060643
Insider Transaction Report
Form 4
McGowan Richard
Director
Transactions
- Disposition to Issuer
Series D Warrant
2014-09-29−264,286→ 0 totalExercise: $0.51From: 2009-03-20Exp: 2016-02-13→ Common Stock (264,286 underlying) - Award
Series D Warrant
2014-09-29+264,286→ 264,286 totalExercise: $0.51From: 2009-03-20Exp: 2018-03-30→ Common Stock (264,286 underlying)
Footnotes (1)
- [F1]The two reported transactions involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on March 20, 2009 and had an original expiration date of February 13, 2016, which was extended to March 30, 2018 pursuant to the terms of the amendment.
Issuer
CLEVELAND BIOLABS INC
CIK 0001318641
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001318641
Filing Metadata
- Form type
- 4
- Filed
- Sep 30, 8:00 PM ET
- Accepted
- Oct 1, 5:47 PM ET
- Size
- 11.3 KB